RU2145323C1 - Производные замещенных 1-(7-хлорхинолин-4-ил)пиразол-3-карбоксамид-n-оксидов, способ их получения, промежуточные соединения и фармацевтическая композиция - Google Patents

Производные замещенных 1-(7-хлорхинолин-4-ил)пиразол-3-карбоксамид-n-оксидов, способ их получения, промежуточные соединения и фармацевтическая композиция Download PDF

Info

Publication number
RU2145323C1
RU2145323C1 RU95113184A RU95113184A RU2145323C1 RU 2145323 C1 RU2145323 C1 RU 2145323C1 RU 95113184 A RU95113184 A RU 95113184A RU 95113184 A RU95113184 A RU 95113184A RU 2145323 C1 RU2145323 C1 RU 2145323C1
Authority
RU
Russia
Prior art keywords
formula
acid
pyrazole
compounds
substituted
Prior art date
Application number
RU95113184A
Other languages
English (en)
Russian (ru)
Other versions
RU95113184A (ru
Inventor
Буажегрэн Робер
Гюлли Даниель
Жанжан Франси
Прадин Антуан
Original Assignee
Санофи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи filed Critical Санофи
Publication of RU95113184A publication Critical patent/RU95113184A/ru
Application granted granted Critical
Publication of RU2145323C1 publication Critical patent/RU2145323C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU95113184A 1994-07-08 1995-07-07 Производные замещенных 1-(7-хлорхинолин-4-ил)пиразол-3-карбоксамид-n-оксидов, способ их получения, промежуточные соединения и фармацевтическая композиция RU2145323C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9408459 1994-07-08
FR9408459A FR2722193B1 (fr) 1994-07-08 1994-07-08 Derives n-oxydes de 1-(7-chloro-4-quinoleinyl)pyrazole-3-carboxamides substitues, procede pour leur preparation et les compositions pharmaceitiques les contenant

Publications (2)

Publication Number Publication Date
RU95113184A RU95113184A (ru) 1997-08-10
RU2145323C1 true RU2145323C1 (ru) 2000-02-10

Family

ID=9465167

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95113184A RU2145323C1 (ru) 1994-07-08 1995-07-07 Производные замещенных 1-(7-хлорхинолин-4-ил)пиразол-3-карбоксамид-n-оксидов, способ их получения, промежуточные соединения и фармацевтическая композиция

Country Status (17)

Country Link
US (1) US5561234A (enExample)
EP (1) EP0695747A1 (enExample)
JP (1) JPH0841051A (enExample)
KR (1) KR960004341A (enExample)
CN (1) CN1042533C (enExample)
AU (1) AU695588B2 (enExample)
CA (1) CA2153432A1 (enExample)
FI (1) FI953360A7 (enExample)
FR (1) FR2722193B1 (enExample)
HU (1) HUT73175A (enExample)
IL (1) IL114500A (enExample)
NO (1) NO952715L (enExample)
NZ (1) NZ272525A (enExample)
PL (1) PL309546A1 (enExample)
RU (1) RU2145323C1 (enExample)
TW (1) TW318847B (enExample)
ZA (1) ZA955673B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2304578C2 (ru) * 2002-03-18 2007-08-20 Солвей Фармасьютикалс Б.В. Нейротензин активные производные 2,3-диарилпиразолидина

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033531A1 (en) * 1997-02-03 1998-08-06 Mallinckrodt Medical, Inc. Method for the detection and localization of malignant human tumours

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU541846A1 (ru) * 1975-10-28 1977-01-05 Донецкое Отделение Физико-Органической Химии Института Физической Химии Им. Л.В.Писаржевского Ан Украинской Сср Способ получени 2-гетерилзамещенных бензимидазола

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5283852A (en) * 1976-01-01 1977-07-13 Christiaens Sa A Pyridine derivatives
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters
JPH02268162A (ja) * 1989-04-10 1990-11-01 Fujisawa Pharmaceut Co Ltd ジフェニルピリジン誘導体
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU541846A1 (ru) * 1975-10-28 1977-01-05 Донецкое Отделение Физико-Органической Химии Института Физической Химии Им. Л.В.Писаржевского Ан Украинской Сср Способ получени 2-гетерилзамещенных бензимидазола

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2304578C2 (ru) * 2002-03-18 2007-08-20 Солвей Фармасьютикалс Б.В. Нейротензин активные производные 2,3-диарилпиразолидина

Also Published As

Publication number Publication date
FI953360L (fi) 1996-01-09
EP0695747A1 (fr) 1996-02-07
ZA955673B (en) 1996-02-20
KR960004341A (ko) 1996-02-23
CA2153432A1 (en) 1996-01-09
NZ272525A (en) 1997-02-24
NO952715D0 (no) 1995-07-07
PL309546A1 (en) 1996-01-22
FI953360A7 (fi) 1996-01-09
HU9502081D0 (en) 1995-09-28
IL114500A0 (en) 1995-11-27
AU695588B2 (en) 1998-08-20
FR2722193A1 (fr) 1996-01-12
FR2722193B1 (fr) 1996-10-04
JPH0841051A (ja) 1996-02-13
CN1042533C (zh) 1999-03-17
NO952715L (no) 1996-01-09
HUT73175A (en) 1996-06-28
AU2486795A (en) 1996-01-18
US5561234A (en) 1996-10-01
TW318847B (enExample) 1997-11-01
IL114500A (en) 1999-11-30
CN1120042A (zh) 1996-04-10
FI953360A0 (fi) 1995-07-07

Similar Documents

Publication Publication Date Title
KR100223074B1 (ko) 3-아미도피라졸 유도체 및 그 제조방법과 그것을 함유한 약학 조성물
JP2514137B2 (ja) キヌクリジン誘導体
JP2656702B2 (ja) ペプチド性キヌクリジン
CN105518005A (zh) 作为rock抑制剂的三环吡啶-甲酰胺衍生物
JP2021523875A (ja) Ｆｇｆｒ阻害剤としてのピラジン−２（１ｈ）−オン系化合物
JPH0570463A (ja) Ｎ−アシル−２，３−ベンゾジアゼピン誘導体、その製造法、それを含有する製剤組成物、およびその製造法
EP3569592B1 (en) Hdac6 selective inhibitors, preparation method therefor, and application thereof
TW202319043A (zh) 3,4-亞甲二氧甲基苯丙胺及相關致幻劑及其用途
FR2582309A1 (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
KR100192833B1 (ko) 4-이실아미노피리딘 유도체 및 그의 제조방법
US4782058A (en) 1,3,4,6,7,11b-Hexahydro-6-phenyl-2H-pyrazino-(2,1-a)isoquinolines, for anti-histamine or anti-depression treatment
IE47481B1 (en) 1-piperidinophthalazine cardiac stimulants
JPH02504394A (ja) フロ〔３，４‐ｃ〕ピリジン鏡像体の立体特異的製造方法、かくして得られた化合物及びこれの製薬組成物
EP2297148B1 (fr) NOUVEAUX DERIVES DE (PIPERAZINYL PONTE)-1-ALCANONE ET LEUR UTILISATION COMME INHIBITEURS DE p75
RU2145323C1 (ru) Производные замещенных 1-(7-хлорхинолин-4-ил)пиразол-3-карбоксамид-n-оксидов, способ их получения, промежуточные соединения и фармацевтическая композиция
EP0234516B1 (de) 1,6-Naphthyridin-Derivate,Verfahren zu deren Herstellung und diese enthaltende Arzneimittel zur Behandlung von Gefässerkrankungen
CA2663080A1 (fr) Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique.
EP0591027A1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique
CS203940B2 (en) Process for preparing aryloktahydropyridines
US20040067959A1 (en) Morphinoid derivatives as delta-opioid agonists and antagonists
JP2546919B2 (ja) ９ーアシルアミノテトラヒドロアクリジン誘導体
IE50006B1 (en) Derivatives of tetrahydropyrid-4-yl-indole
CZ176895A3 (cs) Substituované N-oxidované deriváty l-(7-chlorchinolein-4-yl)-pyrazoI-3-karboxamidů, způsob jejich přípravy a farmaceutické přípravky sjejich obsahem
JPH0568477B2 (enExample)
FI71735B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-substituerade ergolin- och 9,10-didehydroergolin-8-karboxamid- och -8-aminometylderivat